Features, Transmission, Detection, and Case Studies in COVID-19

 
Kiadó: Academic Press
Megjelenés dátuma:
 
Normál ár:

Kiadói listaár:
EUR 220.00
Becsült forint ár:
90 783 Ft (86 460 Ft + 5% áfa)
Miért becsült?
 
Az Ön ára:

72 626 (69 168 Ft + 5% áfa )
Kedvezmény(ek): 20% (kb. 18 157 Ft)
A kedvezmény érvényes eddig: 2024. június 30.
A kedvezmény csak az 'Értesítés a kedvenc témákról' hírlevelünk címzettjeinek rendeléseire érvényes.
Kattintson ide a feliratkozáshoz
 
Beszerezhetőség:

Még nem jelent meg, de rendelhető. A megjelenéstől számított néhány héten belül megérkezik.
 
  példányt

 
Hosszú leírás:
Features, Transmission, Detection, and Case Studies in COVID-19 examines the effects of the virus on the brain, as well as its transmission and clinical profile. Beginning with an introduction to the virus and its pathogenesis, transmission, and avoidance, sections on neurological symptoms and biomarkers in the brain uniquely describe the effects of this virus on this system. Vaccines and treatment are also discussed. Neurological issues covered include brain hypoxia, Parkinson’s disease, and incidence of COVID-19-related acute ischemic stroke. This volume is relevant for all neurologists and clinicians working to ensure the best outcomes and patient care of patients with COVID-19.


  • Describes neurological issues caused by COVID-19, including stroke and loss of taste and smell
  • Discusses COVID-19 biology, including pathogenesis and transmission
  • Outlines biomarkers in the brain associated with severity and disease outcomes
  • Features individual chapter introductions, summaries, and case studies to provide comprehensive descriptions of neurological symptoms
Tartalomjegyzék:

Preface I. SARS-CoV-2 and COVID-19: Introductory chapters and setting the scene 1. Coronavirus Disease 2019 (COVID-19) pandemic in context: Systemic effects 2. Early warning signals of SARS-CoV-2 infection 3. Mobile phones and their use to study dynamics of COVID19 pandemic II. Structure, transmission and avoidance 4. Cis regulatory elements: A novel communication route between the host cell and SARS-CoV-2 genome 5. SARS-CoV-2 ORF8: Structure, Evolution, Molecular Function, and Its Contribution to the Pathogenicity of the Virus 6. SARS-CoV-2 Spike Protein Binding Ligands and Its Application in COVID-19 Therapeutics. 7. Autophagy and COVID-19 8. The Omicron variant of SARS-CoV-2 9. Monitoring SARS-CoV-2 spread in hospitals 10. Computational analysis of mutations in SARS-CoV-2 variants spike protein and protein interactions 11. Airborne transmission of SARS-CoV-2 12. Reducing transmission of SARS-CoV-2 with face masks: its potential protective effects 13. Digital twin of ventilation system against COVID-19 transmission and infection risk 14. SARS-CoV-2 infection and transmission in pets 15. SARS-CoV-2 transmission in dental practices 16. SARS-CoV-2 compared with influenza and respiratory syncytial virus in terms of vertical transmission 17. Reducing droplets and aerosols in the surgical setting and applications to the COVID-19 pandemic 18. SARS-CoV motion dynamics: linking in droplet size 19. Ventilation and airborne particles in classrooms: implications for the COVID-19 pandemic 20. Environmental SARS-CoV-2 transmission and e-cigarette aerosols III. Impact and Effects 21. The Impact of COVID-19 on First Responders 22. COVID-19 and suspected drug-induced liver injury 23. Pulmonary fibrosis in COVID-19 24. The effect of SARS-CoV-2 infection on cancer: clinical correlation and potential pathological mechanism 25. Severe SARS-CoV-2, platelet-endothelium interactions and cardiovascular damage 26. Cardio-metabolic Syndrome and COVID-19: Pathophysiological aspects 27. COVID-19 and Type I and II diabetes: an overview 28. COVID-19 and older adults: an overview 29. COVID-19 and male fertility: an overview 30. COVID-19 and obesity: an overview IV. Treatments, strategies and vaccines 31. COVID-19 vaccines and their impact: an overview 32. Exploring the Promise of COVID-19 Vaccines: A Review of Preclinical Studies 33. Drugs actively being investigated for use in COVID-19 34. The biology of neutralizing antibody cocktail therapy with REGN-COV 35. The intensive care unit and percutaneous tracheostomy in COVID-19 36. Cardiac effects of drugs and vaccines used to treat or prevent COVID -19 37. COVID-19 Pandemic and isolation: impact on sleep 38. Strategies in the COVID-19 pandemic: Disinfection of gloved hands 39. In silico studies on established antivirals on SARS-CoV-2 RNA-dependent RNA polymerase 40. The COVID-19 cytokine storm and its immunomodulatory treatment 41. Safety and efficacy of nebulization for reducing the intensity of viral load and clinical manifestations in patients with COVID-19 V. Detection and biomarkers 42. Bronchoalveolar lavage (BAL) and use in detection of SARS-CoV-2 43. SARS-CoV-2 testing and vaccination among people who use drugs 44. Homocysteine as a biomarker in COVID-19 45. Assessment of smell and taste in COVID-19 46. S-gene analysis: RT-PCR and Sanger sequencing applied to SARS-CoV-2 virus 47. False-negatives in screening for SARS-CoV-2 48. Sample pooling and SARS-CoV-2 assays 49. Biomarkers of Invasive Mechanical Ventilation in Obesity and Metabolic Syndrome VI. Case studies with mini review 50. Hypoxia and heart-lung interactions in COVID-19: The significance of right heart dysfunction and shunt 51. CASE STUDY: Neurology, ulnar nerve dysfunction and COVID-19 52. CASE STUDY: Acute kidney injury and COVID-19 53. CASE STUDY: The detection and treatment of a pneumothorax in a patient with Coronavirus Disease 2019 pneumonia 54. CASE STUDY: Conducting ventilation and airflow studies where airborne outbreaks of SARS-CoV-2 have possibly occurred: preventing recurrence VII. Resources 55. Recommended Resources for the Features, Transmission and Detection of Coronavirus Disease 2019 (COVID-19)